@article{TLCR25506,
author = {Nagio Takigawa and Nobuaki Ochi and Hiromichi Yamane},
title = {Blocking both epidermal growth factor receptor and mesenchymal-to-epithelial transition pathways in EGFR-mutated lung cancer},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 4},
year = {2018},
keywords = {},
abstract = {Although most of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) is sensitive to EGFR tyrosine kinase inhibitor (TKI), the tumor becomes resistant to the drug after around 1 year.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/25506}
}